Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

Alasdair Macgowan; Fergus Hamilton; Mark Bayliss; Liam Read; Marie Attwood; Alan Noel; Maha Albur; Sally Grier; Anna Morley; David Arnold; Nicholas Maskell

doi:10.1089/mdr.2021.0259

Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

Alasdair Macgowan^*, Fergus Hamilton, Mark Bayliss, Liam Read, Marie Attwood, Alan Noel, Maha Albur, Sally Grier, Anna Morley, David Arnold, Nicholas Maskell

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

Original language	English
Pages (from-to)	611-612
Number of pages	2
Journal	Microbial Drug Resistance
Volume	28
Issue number	5
DOIs	https://doi.org/10.1089/mdr.2021.0259
Publication status	Published - 1 May 2022

Bibliographical note

Funding Information:
We would like to acknowledge the support from the clinical and nonclinical staff involved in delivering this study.

Research Groups and Themes

Academic Respiratory Unit

Access to Document

10.1089/mdr.2021.0259

Handle.net

Persistent link

Cite this

@article{2880029644654c04ac870d915509fc64,

title = "Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care",

author = "Alasdair Macgowan and Fergus Hamilton and Mark Bayliss and Liam Read and Marie Attwood and Alan Noel and Maha Albur and Sally Grier and Anna Morley and David Arnold and Nicholas Maskell",

note = "Funding Information: We would like to acknowledge the support from the clinical and nonclinical staff involved in delivering this study.",

year = "2022",

month = may,

day = "1",

doi = "10.1089/mdr.2021.0259",

language = "English",

volume = "28",

pages = "611--612",

journal = "Microbial Drug Resistance",

issn = "1076-6294",

publisher = "Mary Ann Liebert Inc.",

number = "5",

}

TY - JOUR

T1 - Letter to the Editor

T2 - Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

AU - Macgowan, Alasdair

AU - Hamilton, Fergus

AU - Bayliss, Mark

AU - Read, Liam

AU - Attwood, Marie

AU - Noel, Alan

AU - Albur, Maha

AU - Grier, Sally

AU - Morley, Anna

AU - Arnold, David

AU - Maskell, Nicholas

N1 - Funding Information: We would like to acknowledge the support from the clinical and nonclinical staff involved in delivering this study.

PY - 2022/5/1

Y1 - 2022/5/1

UR - http://www.scopus.com/inward/record.url?scp=85130643934&partnerID=8YFLogxK

U2 - 10.1089/mdr.2021.0259

DO - 10.1089/mdr.2021.0259

M3 - Letter (Academic Journal)

C2 - 35099290

AN - SCOPUS:85130643934

SN - 1076-6294

VL - 28

SP - 611

EP - 612

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

IS - 5

ER -

Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

Bibliographical note

Research Groups and Themes

Access to Document

Handle.net

Other files and links

Cite this